“HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome” (2015) University of Thi-Qar Journal of Science, 5(3), pp. 48–56. doi:10.32792/utq/utjsci/v5i3.138.